Supernus Pharmaceuticals, Inc.【SUPN】 業績推移・財務諸表

機能の使い方
(単位:千ドル) 1Q12 2Q12 3Q12 4Q12 1Q13 2Q13 3Q13 4Q13 1Q14 2Q14 3Q14 4Q14 1Q15 2Q15 3Q15 4Q15 1Q16 2Q16 3Q16 4Q16 1Q17 2Q17 3Q17 4Q17 1Q18 2Q18 3Q18 4Q18 1Q19 2Q19 3Q19 4Q19 1Q20 2Q20 3Q20 4Q20 1Q21 2Q21 3Q21 4Q21 1Q22 2Q22 3Q22 4Q22 1Q23 2Q23 3Q23 4Q23 1Q24 2Q24 3Q24 4Q24 1Q25 2Q25 3Q25 4Q25
売上高 208 91 91 1,090 147 281 1,257 10,334 9,081 29,675 52,488 30,801 28,133 35,052 38,586 42,655 43,075 50,421 56,810 62,374 57,576 75,829 80,398 88,435 90,429 99,538 102,996 115,934 85,474 104,695 102,140 100,446 94,976 126,729 155,135 143,557 130,932 141,329 148,464 159,050 152,506 170,051 177,353 167,328 153,764 135,563 153,880 164,314 143,644 168,325 175,689 174,159 149,824 165,453 192,103 211,572
売上成長率(%) - - - - 6.0 4.3 -1.7 9.3 21.5
売上原価 - - - - - 4 33 1,067 494 1,661 1,321 2,282 1,618 1,762 2,248 2,795 2,035 2,751 3,428 3,772 2,949 3,861 4,251 4,155 3,278 3,683 4,207 4,188 3,684 4,044 4,819 4,113 4,152 8,386 21,388 18,533 14,954 25,028 18,085 - 17,932 20,457 25,878 - 23,460 21,091 19,601 - 16,309 17,916 17,583 26,098 15,763 16,827 18,965 23,007
研究開発費 5,358 4,703 8,306 5,150 4,522 3,542 3,779 5,401 4,482 4,677 4,657 5,770 3,683 6,878 9,129 9,445 10,562 11,109 7,868 13,252 9,601 10,823 12,980 16,172 18,908 20,038 20,422 29,841 15,394 16,970 16,943 19,792 18,937 22,247 16,839 17,938 34,280 15,455 19,654 21,078 20,839 16,385 19,554 17,774 21,212 24,379 22,655 23,347 24,930 26,183 29,036 28,647 26,927 22,115 29,366 27,827
販売管理費 - 4,645 4,075 8,682 13,533 12,214 14,620 15,224 17,527 19,581 17,343 18,019 19,402 23,336 22,900 23,567 25,160 26,121 25,675 29,054 28,238 35,078 40,825 33,764 36,849 40,097 40,892 42,050 40,968 41,083 40,649 35,725 42,875 48,103 54,660 56,300 61,457 69,535 72,032 101,735 90,459 100,476 112,314 73,972 85,597 86,782 82,700 81,282 86,516 85,904 69,753 79,409 89,944 93,551 179,678 122,390
営業費用 8,086 9,348 12,381 13,834 18,055 15,760 18,432 21,691 22,503 25,919 23,321 26,072 24,703 31,976 34,277 35,806 37,757 39,981 36,971 46,078 40,788 49,762 58,056 54,091 59,035 63,818 65,521 76,079 60,046 62,097 62,411 59,630 65,964 81,181 98,995 100,559 117,718 107,216 115,860 152,952 150,539 158,705 178,876 132,994 148,588 153,150 145,742 165,310 146,797 145,756 134,844 152,754 160,080 153,312 252,334 215,509
営業利益 -7,878 -9,257 -12,290 -12,743 -17,908 -15,479 -17,175 -11,357 -13,422 3,756 29,167 4,730 3,430 3,076 4,309 6,849 5,318 10,440 19,839 16,296 16,788 26,067 22,342 34,344 31,394 35,720 37,475 39,855 25,428 42,598 39,729 40,816 29,012 45,548 56,140 42,998 13,214 34,113 32,604 6,098 1,967 11,346 -1,523 34,334 5,176 -17,587 8,138 -996 -3,153 22,569 40,845 21,405 -10,256 12,141 -60,231 -3,937
営業利益率 (%) 12.3 -6.8 7.3 -31.4 -1.9
経常(税引前)利益 - - - - - - - - - - - - 979 2,667 4,280 7,045 5,185 10,732 19,136 15,552 16,223 26,425 22,910 35,060 31,182 33,856 36,371 38,767 24,239 42,746 39,590 40,912 29,034 47,210 52,711 39,693 10,929 31,235 28,960 2,051 14,723 11,324 -444 35,140 9,017 -17,127 9,889 990 243 26,302 44,943 26,382 -5,831 16,669 -57,954 -1,914
経常(税引前)利益率(%) - - - - - - - - - - - - 3.5 7.6 11.1 16.5 12.0 21.3 33.7 24.9 28.2 34.8 28.5 39.6 34.5 34.0 35.3 33.4 28.4 40.8 38.8 40.7 30.6 37.3 34.0 27.6 8.3 22.1 19.5 1.3 9.7 6.7 -0.3 21.0 5.9 -12.6 6.4 0.6 0.2 15.6 25.6 15.1 -3.9 10.1 -30.2 -0.9
法人税等合計 - - - - - - - - - - - - 62 662 58 174 198 714 -42,690 1,233 5,926 9,057 6,949 21,402 4,830 3,119 8,360 12,874 5,899 10,019 10,730 7,783 7,516 12,543 12,714 8,925 5,235 7,509 7,398 -391 -10,893 3,459 -2,193 9,659 -7,900 -16,300 25,900 -147 100 6,400 6,446 11,005 6,000 -5,800 -12,800 2,220
実効税率(%) - - - - - - - - - - - - 41.7 -102.9 -34.8 22.1 -116.0
純利益 -9,277 -10,013 -13,482 -13,512 -18,414 -27,357 -24,096 -22,406 -15,543 3,202 27,858 4,354 917 2,005 4,222 6,872 4,987 10,018 61,826 14,320 10,297 17,368 15,961 13,658 26,352 30,737 28,011 25,893 18,340 32,727 28,860 33,129 21,518 34,667 39,997 30,768 5,694 23,726 21,562 2,442 25,616 7,865 1,749 25,481 16,948 -831 -15,976 1,175 124 19,916 38,497 15,328 -11,827 22,499 -45,117 -4,105
純利益率(%) 8.8 -7.9 13.6 -23.5 -1.9
一株あたり利益 - - - - - - - - - 0.08 0.65 0.1 0.02 0.04 0.09 0.14 0.1 0.2 1.25 0.29 0.21 0.34 0.31 0.27 0.51 0.59 0.54 0.5 0.35 0.62 0.55 0.63 0.41 0.66 0.76 0.58 0.11 0.45 0.41 0.05 0.48 0.15 0.03 0.47 0.31 -0.02 -0.29 - 0 0.36 0.7 0.28 -0.21 0.4 -0.8 -0.07
希薄化後一株あたり利益 - - - - - - - - - 0.08 0.39 0.1 0.02 0.03 0.08 0.14 0.08 0.18 1.18 0.26 0.19 0.32 0.29 0.26 0.49 0.57 0.52 0.48 0.34 0.61 0.54 0.62 0.4 0.65 0.74 0.57 0.11 0.43 0.4 0.04 0.43 0.14 0.03 0.42 0.29 -0.02 -0.29 - 0 0.36 0.69 0.27 -0.21 0.4 -0.8 -0.07
EBITDA 40,250 10,127 33,499 -35,425 21,079
EBITDAマージン(%) 23.1 6.8 20.2 -18.4 10.0